Return to Listing

4 result(s) for

PI Name Protocol # Title
Raymond Bergan STUDY00015588 Serial Measurements of Molecular and Architectural Responses to Therapy
Christopher Ryan STUDY00018121 A Phase 3, Randomized, Open-Label Study of Nivolumab Combined with Cabozantinib versus Sunitinib in Participants with Previously Untreated, Advanced or Metastatic Renal Cell Carcinoma
Michael Heinrich STUDY00019262 A Phase 3, Interventional, Randomized, Multicenter, Open-Label Study of DCC-2618 vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumors after Treatment with Imatinib (INTRIGUE)
Christopher Ryan STUDY00019992 [NCI CIRB] MATCH - EAY131 - Molecular Analysis for Therapy Choice (MATCH)
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080